Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer

Androgen deprivation therapy (ADT) with medical or surgical castration is the mainstay of therapy in men with metastatic prostate cancer. However, despite initial responses, almost all men eventually develop castration refractory metastatic prostate cancer (CRPC) and die of their disease. Over the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Jesal C., Maughan, Benjamin L., Agarwal, Archana M., Batten, Julia A., Zhang, Tian Y., Agarwal, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684034/
https://www.ncbi.nlm.nih.gov/pubmed/23819055
http://dx.doi.org/10.1155/2013/981684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684034/
https://www.ncbi.nlm.nih.gov/pubmed/23819055
http://dx.doi.org/10.1155/2013/981684

Ejemplares similares